Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting NewsPerspective

Gut bacteria may be factor in rising colorectal cancer incidence among younger adults

January 27, 2020
Fusobacterium nucleatum may be partially responsible for the sharp increase in colorectal cancer incidence among individuals aged younger than 45…
Meeting NewsPerspective

Blood test could lead to earlier detection of gastrointestinal cancers

January 24, 2020
An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various…
Meeting NewsPerspective

Encorafenib regimens confer quality-of-life, survival benefit in BRAF V600E-mutant metastatic colorectal cancer

January 23, 2020
A combination of encorafenib and cetuximab, with or without binimetinib, demonstrated significant improvement in patient-reported quality-of-life…
Meeting NewsPerspective

Sociodemographic factors may influence survival among young adults with colorectal cancer

January 22, 2020
Young adults with colorectal cancer who resided in areas with the lowest incomes and high school graduation rates had a 24% increased risk for death…
Meeting News

Atezolizumab-bevacizumab combination delays quality-of-life deterioration in hepatocellular carcinoma

January 22, 2020
Atezolizumab in combination with bevacizumab delayed time to deterioration of quality of life, physical functioning and role functioning compared…
Meeting NewsPerspective

Stereotactic body radiation shows sustained local control in hepatocellular carcinoma

January 23, 2019
Stereotactic body radiation therapy showed promising rates of local control and survival in patients diagnosed with early-stage
Meeting News

Adjuvant durvalumab safe, active for locally advanced esophageal adenocarcinoma

January 17, 2019
Adjuvant durvalumab administered after trimodality therapy appeared safe for patients with locally advanced esophageal and gastroesophageal junction…
Meeting NewsPerspective

Pembrolizumab reduces mortality risk in advanced PD-L1-positive esophageal cancer

January 15, 2019
Pembrolizumab significantly improved OS compared with chemotherapy as second-line treatment for patients with advanced or metastatic esophageal or…
Meeting NewsPerspective

Pembrolizumab induces durable responses in advanced liver cancer

January 23, 2018
Pembrolizumab treatment led to durable OS and PFS among patients with advanced hepatocellular carcinoma who previously progressed on sorafenib…
Meeting News

Sorafenib plus transarterial chemoembolization improves PFS in unresectable hepatocellular carcinoma

January 19, 2018
The addition of sorafenib to transarterial chemoembolization improved PFS among patients with unresectable hepatocellular carcinoma, according to…